The emergence of novel psychoactive substances presents a unique scenario for researchers and policymakers alike. Among these, 2-FDCK has gained prominence as a potent dissociative agent with limited pharmacological properties. Initial studies suggest that 2-FDCK may produce comparable effects to other dissociatives, such as ketamine, but its preci